Susquehanna International Group, LLP Macrogenics Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $4,500 - $8,325	1,500 Added 3.77%	41,300 $135,000
Q2 2024 Aug 15, 2024	SELL	$3.31 - $18.51 $193,966 - $1.08 Million	-58,600 Reduced 59.55%	39,800 $169,000
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $774,761 - $1.7 Million	79,300 Added 415.18%	98,400 $1.45 Million
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $11,648 - $26,286	2,600 Added 15.76%	19,100 $183,000
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $73,920 - $102,135	16,500 New	16,500 $76,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $31,905 - $55,332	10,600 New	10,600 $37,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $119,325 - $164,100	7,500 Added 75.76%	17,400 $279,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $665,238 - $967,190	-33,700 Reduced 77.29%	9,900 $207,000
Q2 2021 Aug 11, 2021	SELL	$20.49 - $35.63 $471,269 - $819,490	-23,000 Reduced 34.53%	43,600 $1.17 Million
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $311,436 - $544,480	16,400 Added 32.67%	66,600 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $1.62 Million - $2.08 Million	-65,800 Reduced 56.72%	50,200 $1.27 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $349,960 - $1.96 Million	67,300 Added 138.19%	116,000 $3.24 Million
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $60,420 - $93,252	-7,600 Reduced 13.5%	48,700 $530,000
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $501,332 - $704,444	-40,300 Reduced 41.72%	56,300 $718,000
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $333,730 - $453,330	23,000 Added 31.25%	96,600 $1.64 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $134,431 - $309,760	12,100 Added 19.67%	73,600 $1.32 Million
Q4 2017 Feb 14, 2018	BUY	$16.19 - $20.3 $351,323 - $440,510	21,700 Added 54.52%	61,500 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $617,696 - $753,812	39,800	39,800 $736,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$33.2 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.9 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$18 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.6 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.8 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $205M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account